Marshall & Sterling Wealth Advisors Inc. has filed a Form 13F-HR with the U.S. Securities and Exchange Commission, disclosing its equity holdings as of the close of business on September 30, 2026. The filing lists 369 distinct positions held by the firm.
The report indicates that the firm's total equity portfolio consists of 369 holdings. The filing lists a total of 369 positions, with the largest holding listed as 4D MOLECULAR Common Stock, for which the firm holds 1,431 shares.
Among the other notable positions disclosed in the filing are:
- Abbott Laboratories (511,517 shares)
- AbbVie Inc. (451,244 shares)
- Alphabet Inc. (930,340 shares)
- American Tower (147,3 shares)
- Apple Inc. (2,321,010 shares)
- Berkshire Hathaway (1,362,392 shares)
- BlackRock FDG (2,117 shares)
- Broadcom Inc. (620,033 shares)
- Caterpillar Inc. (171,161 shares)
- Costco Wholesale (586,504 shares)
- CrowdStrike Holdings (983,283 shares)
- ExxonMobil Holdings (324,506 shares)
- Home Depot (541,519 shares)
- Intel Corp. (42,681 shares)
- Johnson & Johnson (11,384 shares)
- Lockheed Martin (590,434 shares)
- Lowes Companies (107,104 shares)
- UnitedHealth Group (1,451,999 shares)
- Visa Inc. (575,053 shares)
- Walmart Inc. (797,281 shares)
The filing also includes a significant number of exchange-traded funds and mutual funds, including holdings in the iShares family of funds, such as iShares Core S&P 500 ETF, iShares MSCI World ETF, and iShares Semiconductor ETF.
The report was signed by Craig M. Pesce, the Chief Compliance Officer of Marshall & Sterling Wealth Advisors Inc., and was filed on October 28, 2026.
